For the Inventor, By the Inventor

Enter inventor name

Redwood City, CA, United States of America

Michael O Clarke

USPTO Granted Patents = 14 (Patent Applications = 16)

EPO Patents = 4 (Patent Applications = 13)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Grand Rapids Township, MI (US) (2012)
Redwood City, CA (US) (2011 - 2024)

Company Filing History:

Gilead Sciences, Inc.

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12404289 - 1'-cyano nucleoside analogs and uses thereof (2025-09-02),

2. 12264173 - Antiviral compounds (2025-04-01),

3. 12116380 - Phospholipid compounds and methods of making and using the same (2024-10-15),

4. 12110305 - Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use (2024-10-08),

5. 12110294 - CD73 compounds (2024-10-08),

6. 12030903 - Antiviral compounds (2024-07-09),

7. 11939347 - 1′-cyano nucleoside analogs and uses thereof (2024-03-26),

8. 11919869 - CD73 compounds (2024-03-05),

9. 11767337 - Antiviral compounds (2023-09-26),

10. 11718637 - Prodrugs of 4'-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same (2023-08-08),

11. 8674088 - Antiviral phosphinate compounds (2014-03-18),

12. 8586744 - Antiviral phosphinate compounds (2013-11-19),

13. D662810 - Strain relief nut (2012-07-03),

14. 7893264 - Antiviral phosphinate compounds (2011-02-22),

Title: Michael O Clarke: Innovator in Antiviral Compounds

Introduction

Michael O Clarke is a prominent inventor based in Redwood City, CA, known for his significant contributions to the field of antiviral research. With a total of 14 patents to his name, Clarke has made remarkable strides in developing compounds that target various viral infections.

Latest Patents

Among his latest patents are the innovative 1'-cyano nucleoside analogs and their uses. These compounds and methods are designed for treating viral infections, either alone or in combination with additional agents. Another notable patent focuses on antiviral compounds that provide treatment options for a range of diseases, including respiratory syncytial virus (RSV), human rhinovirus (HRV), human metapneumovirus (hMPV), Ebola, Zika, West Nile, Dengue, and hepatitis C virus (HCV).

Career Highlights

Michael O Clarke is currently associated with Gilead Sciences, Inc., where he continues to advance his research in antiviral therapies. His work has been instrumental in developing effective treatments that address critical health challenges posed by viral infections.

Collaborations

Clarke has collaborated with notable colleagues, including Richard L Mackman and Dustin S Siegel, to further enhance the impact of his research and innovations in the field.

Conclusion

Michael O Clarke's contributions to antiviral research and his impressive portfolio of patents underscore his role as a leading inventor in the fight against viral diseases. His ongoing work at Gilead Sciences, Inc. continues to pave the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…